在败血症中PAMP和DAMP:对它们的分子特征和潜在临床影响的审查
Sara Cicchinelli1, Giulia Pignataro2, Stefania Gemma2
1Department of Emergency, S.S. Filippo e Nicola Hospital, 67051 Avezzano, Italy.
International journal of molecular sciences
|January 23, 2024
概括
本综述探讨了早期败血症中的病原体和危险相关分子模式 (PAMP/DAMP). 了解这些分子触发器可能会导致新的生物标志物和毒症患者的向治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 关键护理医学 关键护理医学
背景情况:
- 败血症是一种危及生命的器官功能障碍,由免疫反应对感染的失调驱动.
- 天生的免疫能迅速检测到保存的微生物分子 (PAMP) 和宿主衍生的危险信号 (DAMP).
研究的目的:
- 审查早期败血症的分子机制,重点关注PAMP,DAMP和相关途径.
- 为了确定毒症诊断和预后的潜在生物标志物.
- 为了阐明败血症预后得分的分子基础.
主要方法:
- 对英语语言研究的系统文献综述.
- 在PubMed和Cochrane数据库中进行的搜索.
- 分析PAMP/DAMP在败血症影响器官中的作用和预后得分.
主要成果:
- 详细讨论当前关于血红病中PAMP和DAMP的知识.
- 分析PAMP/DAMP在败血症期间器官功能障碍中的参与.
- 对PAMP/DAMP的时间释放模式的识别.
结论:
- PAMPs/DAMPs途径为败血症生物标志物发现和向治疗提供了有希望的途径.
- 这些发现是初步的;病原体和宿主因素显著影响这些途径.
- 进一步的研究对于将这些分子见解转化为治疗败血症的临床实践至关重要.
相关概念视频
Antimicrobial Proteins
994
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
994
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Pneumonia III: Complications and Assessment
227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227


